The gastroprotective effect of red propolis extract from Northeastern Brazil and the role of its isolated compounds.


Journal

Journal of ethnopharmacology
ISSN: 1872-7573
Titre abrégé: J Ethnopharmacol
Pays: Ireland
ID NLM: 7903310

Informations de publication

Date de publication:
01 Mar 2021
Historique:
received: 16 08 2020
revised: 26 10 2020
accepted: 23 11 2020
pubmed: 28 11 2020
medline: 3 3 2021
entrez: 27 11 2020
Statut: ppublish

Résumé

Propolis has been used in folk medicine to treat gastric disorders for centuries. However, although studies have been conducted to validate the gastroprotective and anti-ulcer activity of some types of propolis, red propolis activity remains unknown. The present study aimed to evaluate the gastroprotective effect of the hydroalcoholic extract of red propolis (HERP), its mode of action, and the main compounds involved in its activity, therefore contributing to validate the chemical and pharmacological potential of this product. The effect of HERP (30, 100 and 300 mg/kg p.o. and 30 mg/kg i.p.), and the isolated compounds vestitol (VS), neovestitol (NV), methylvestitol (MV), medicarpin (MD), and oblongifolin AB (OB) (10 mg/kg p.o.) were evaluated on gastric ulcers induced by 60% ethanol/0.3 M HCl (5 mL/kg, p.o.) in mice. Histological changes and mucin levels were assessed by HE and PAS, respectively. Moreover, oxidative stress parameters and myeloperoxidase activity were analyzed on ulcerated tissue. The effect of HERP on gastric acid secretion was evaluated by pyloric ligature model and the mechanisms involved in its gastroprotective effect were investigated by pretreating mice with L-NAME (a non-selective nitric oxide synthase inhibitor, 70 mg/kg, i.p.), NEM (a sulfhydryl group chelator, 10 mg/kg, i.p.), yohimbine (an alpha-adrenergic receptor antagonist, 2 mg/kg, i.p.) and indomethacin (a non-selective cyclooxygenase inhibitor, 10 mg/kg, i.p.). HERP (300 mg/kg p.o. or 30 mg/kg i.p.), MV, and MD (10 mg/kg p.o.) protected gastric mucosa against the damage induced by ethanol/HCl. Histological changes were attenuated by the HERP, MV, and MD. Moreover, HERP and MV increased mucin levels. Besides, oxidative stress and MPO activity were reduced by the three treatments. HERP did not display anti-secretory action, but its effect was abolished by indomethacin treatment. HERP displays gastroprotective property against ethanol/HCl-induced damage. Its effect is dependent on prostaglandins and mucin production. The compounds MV and MD may have an essential role in the activity of HERP. Our data contribute to validate the traditional use of propolis for gastric disorders.

Identifiants

pubmed: 33246124
pii: S0378-8741(20)33511-X
doi: 10.1016/j.jep.2020.113623
pii:
doi:

Substances chimiques

Anti-Ulcer Agents 0
Gastric Mucins 0
Prostaglandins 0
Ethanol 3K9958V90M
Propolis 9009-62-5
Hydrochloric Acid QTT17582CB

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

113623

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Auteurs

Thaise Boeing (T)

School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil. Electronic address: tize.thaise@gmail.com.

Jennyfer Andrea Aldana Mejía (JAA)

School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil. Electronic address: j.aldana@usp.br.

Gari Vidal Ccana-Ccapatinta (GV)

School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil. Electronic address: ccana.ccapatinta@gmail.com.

Marihá Mariott (M)

Postgraduate Program in Pharmaceutical Sciences (PPGCF), Nucleus for Chemical-Pharmaceutical Investigations (NIQFAR), University of Vale Do Itajaí (UNIVALI), Itajaí, SC, Brazil. Electronic address: marii_mariott@yahoo.com.br.

Rita de Cássia Melo Vilhena de Andrade Fonseca Da Silva (RC)

Postgraduate Program in Pharmaceutical Sciences (PPGCF), Nucleus for Chemical-Pharmaceutical Investigations (NIQFAR), University of Vale Do Itajaí (UNIVALI), Itajaí, SC, Brazil. Electronic address: ritacvilhena@hotmail.com.

Priscila de Souza (P)

Postgraduate Program in Pharmaceutical Sciences (PPGCF), Nucleus for Chemical-Pharmaceutical Investigations (NIQFAR), University of Vale Do Itajaí (UNIVALI), Itajaí, SC, Brazil. Electronic address: priscilasouza_rc@yahoo.com.br.

Luisa Nathália Bolda Mariano (LNB)

Postgraduate Program in Pharmaceutical Sciences (PPGCF), Nucleus for Chemical-Pharmaceutical Investigations (NIQFAR), University of Vale Do Itajaí (UNIVALI), Itajaí, SC, Brazil. Electronic address: luhbolda_@hotmail.com.

Graziela Regina Oliveira (GR)

Postgraduate Program in Pharmaceutical Sciences (PPGCF), Nucleus for Chemical-Pharmaceutical Investigations (NIQFAR), University of Vale Do Itajaí (UNIVALI), Itajaí, SC, Brazil. Electronic address: graziela-ro27@hotmail.com.

Isabelle Moraes da Rocha (IM)

Postgraduate Program in Pharmaceutical Sciences (PPGCF), Nucleus for Chemical-Pharmaceutical Investigations (NIQFAR), University of Vale Do Itajaí (UNIVALI), Itajaí, SC, Brazil. Electronic address: isabellemoraesdarocha@hotmail.com.

Gabriela Altini da Costa (GA)

Postgraduate Program in Pharmaceutical Sciences (PPGCF), Nucleus for Chemical-Pharmaceutical Investigations (NIQFAR), University of Vale Do Itajaí (UNIVALI), Itajaí, SC, Brazil. Electronic address: gabialtini@hotmail.com.

Sérgio Faloni de Andrade (SF)

Postgraduate Program in Pharmaceutical Sciences (PPGCF), Nucleus for Chemical-Pharmaceutical Investigations (NIQFAR), University of Vale Do Itajaí (UNIVALI), Itajaí, SC, Brazil; Universidade Lusófona - CBIOS - Research Center for Biosciences and Health Technologies, Av. Campo Grande, 376, 1749-024, Lisboa, Portugal. Electronic address: sfaloni@gmail.com.

Luísa Mota da Silva (LM)

Postgraduate Program in Pharmaceutical Sciences (PPGCF), Nucleus for Chemical-Pharmaceutical Investigations (NIQFAR), University of Vale Do Itajaí (UNIVALI), Itajaí, SC, Brazil. Electronic address: lu.isamota@hotmail.com.

Jairo Kenupp Bastos (JK)

School of Pharmaceutical Sciences of Ribeirão Preto, University of São Paulo, Ribeirão Preto, São Paulo, Brazil. Electronic address: jkbastos@fcfrp.usp.br.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH